use of cetirizine in infants 3-6 months

Evaluation of side effects of cetirizine syrup in infants 3-6 months with urticaria and atopic dermatitis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20110531006660N8

Enrollment

Registered

2020-03-31

Start date

2018-04-21

Completion date

Unknown

Last updated

2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cetirizine.

Interventions

All of patients use cetirizine ( 0.25 mg/kg/day) for 10 days.

Eligibility

Sex/Gender

All

Age

3 Months to 6 Months

Inclusion criteria

Inclusion criteria: infants with 3-6 months age;urticaria;eczema

Exclusion criteria

Exclusion criteria: sleep apnea in infant or another siblings sensitivity to cetirizine use of other antihistamines QT interval more than 45 ms

Design outcomes

Primary

Measure	Time frame
Clinical resolution of urticaria and eczema. Timepoint: Before and after 10 days treatment. Method of measurement: Visit and ECG.	—

Secondary

Measure	Time frame
Side effects of drug. Timepoint: 10 days. Method of measurement: Visit and ECG.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJavad Ghaffari

Mazandaran University of Medical Sciences

Javadneg@yahoo.com+98 11 3324 9804

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026